Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...

Eli Lilly (LLY 0.40%) and Novo Nordisk (NVO 1.97%) are two phenomenal growth stocks that investors probably can't go wrong ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

Bosses from Fortune 500 Europe companies including Novo Nordisk, Lego, and Carlsberg met with the PM as Trump ups his threats over Greenland.

Novo Nordisk A/S is prepared for potential tariffs from US President Donald Trump, the Danish drugmaker’s chief executive said, as tensions simmer between Copenhagen and Washington.

And last month, Mr. Trump threatened tariffs on Denmark, Novo Nordisk’s home country, in a spat over Greenland. Novo Nordisk manufacturers some of its drugs in the United States, but it still ...

Novo, which competes with U.S. drugmaker Eli Lilly, makes the main active ingredient in its popular obesity and diabetes injections Wegovy and Ozempic in Denmark, and exports it to the United States.

Novo Nordisk's U.S.-listed shares fell close to 6% Monday after the drugmaker revealed the latest results for a new weight-loss treatment.

Ozempic is so popular that Novo Nordisk’s market value has skyrocketed to almost $300 billion. If Trump imposes steep tariffs on Denmark, it could at least temporarily increase the consumer ...

President-elect Donald Trump’s quest to buy Greenland from Denmark could make Ozempic and Wegovy, the weight-loss and diabetes drugs exploding in popularity, even more expensive for Americans.

Each package of Ozempic costs nearly $1,000, prior to discounts or insurance, according to Novo Nordisk. Wegovy is listed above $1,300 per package. Already, the American price is many times higher ...